• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Oruka Therapeutics, Inc. - Common Stock (NQ:ORKA)

    33.12 +0.44 (+1.35%)
    Streaming Delayed Price Updated: 10:29 AM EST, Feb 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 34,709
    Open 32.65
    Bid (Size) 33.11 (100)
    Ask (Size) 33.29 (200)
    Prev. Close 32.68
    Today's Range 32.46 - 33.69
    52wk Range 5.485 - 36.51
    Shares Outstanding 14,410,143
    Dividend Yield 58.44%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Oruka Therapeutics to Participate in Multiple Upcoming Conferences
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Oruka Therapeutics Announces Positive Interim Phase 1 Data for ORKA-002 and Initiation of EVERLAST-B Trial of ORKA-001
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +17.2%
    +17.2%
    1 Month
    -0.3%
    -0.3%
    3 Month
    +20.7%
    +20.7%
    6 Month
    +127.5%
    +127.5%
    1 Year
    +201.1%
    +201.1%

    More News

    Read More
    News headline image
    Oruka Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire
    MoonLake Stock Climbs After-Hours: Retail Traders Shrug Off Record Plunge, More Wall Street Downgrades ↗
    Via Stocktwits
    News headline image
    Oruka Therapeutics Announces New Board Member and Board Transition
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    This Gilead Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗
    Via Benzinga
    News headline image
    AutoZone To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Thursday ↗
    Via Benzinga
    News headline image
    Oruka Therapeutics Inc (NASDAQ:ORKA) Reports Q3 2025 Results, Beats EPS Estimates and Provides Clinical Pipeline Updates ↗
    Via Chartmill
    News headline image
    Oruka Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    The Insider Report: The Bulls Can Thank Tech ↗
    Via Benzinga
    News headline image
    Oruka Therapeutics to Present at Multiple November Investor Conferences
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Stock Market Today: Nasdaq, S&P 500 Futures Rise As Government Enters 2nd Week Of Shutdown—Plug, Lithium Americas, UiPath In Focus ↗
    Via Benzinga
    Topics Stocks
    News headline image
    Constellation Brands, Aehr Test Systems And 3 Stocks To Watch Heading Into Monday ↗
    Via Benzinga
    News headline image
    MoonLake Crashes 89% On Mixed Results For Skin Disease Treatment ↗
    Via Investor's Business Daily
    News headline image
    Wednesday's session: gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    Lyft, Oruka Therapeutics, Roivant Sciences, Workday And Other Big Stocks Moving Higher On Wednesday ↗
    Via Benzinga
    News headline image
    Oruka Therapeutics, Up 20%, Is Trying To Take On AbbVie's Biggest Moneymaker ↗
    Via Investor's Business Daily
    News headline image
    Discover the top movers in Wednesday's pre-market session. ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Why New Fortress Energy Shares Are Trading Higher By 41%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Oruka Therapeutics Announces $180 Million Private Placement
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Oruka Therapeutics Announces Positive Interim Phase 1 Results for ORKA-001
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Oruka Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Oruka Therapeutics Announces IND Clearance for EVERLAST-A Phase 2a Trial of ORKA-001 in Psoriasis with Phase 1 Data to be Presented at EADV in September
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Oruka Therapeutics Announces Promotion of Laura Sandler to Chief Operating Officer
    From Oruka Therapeutics, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Oruka Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Oruka Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Oruka Therapeutics, Inc. - Common Stock trade on?
    Oruka Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Oruka Therapeutics, Inc. - Common Stock?
    The ticker symbol for Oruka Therapeutics, Inc. - Common Stock is ORKA on the Nasdaq Stock Market
    What is the current price of Oruka Therapeutics, Inc. - Common Stock?
    The current price of Oruka Therapeutics, Inc. - Common Stock is 33.12
    When was Oruka Therapeutics, Inc. - Common Stock last traded?
    The last trade of Oruka Therapeutics, Inc. - Common Stock was at 02/18/26 10:29 AM ET
    What is the market capitalization of Oruka Therapeutics, Inc. - Common Stock?
    The market capitalization of Oruka Therapeutics, Inc. - Common Stock is 477.26M
    How many shares of Oruka Therapeutics, Inc. - Common Stock are outstanding?
    Oruka Therapeutics, Inc. - Common Stock has 477M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.